Notice of Adoption for the "Innovative Cancer Medical Practical Research Project" by the Japan Agency for Medical Research and Development (AMED) for Fiscal Year 2024.

We are pleased to announce that the research theme on diagnostic technology using biomarkers for early-stage liver cancer, in which our company and Perseus Proteomics Co., Ltd. are participating, and which is led by Associate Professor Koji Yamada from the Department of Biochemistry at Tokyo Medical University, has been selected for the "Innovative Cancer Medical Practical Research Project" publicly solicited by the Japan Agency for Medical Research and Development (AMED). For more details, please visit our company's website.

Inquiry about this news
Contact Us Online